Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Malignant Melanoma

  Free Subscription


17.06.2019

1 Ann Surg
1 Ann Surg Oncol
1 Anticancer Res
1 Cancer Res
1 Clin Cancer Res
1 J Invest Dermatol
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Surg

  1. THOMPSON JF, Haydu LE, Uren RF, Andtbacka RH, et al
    Preoperative Ultrasound Assessment of Regional Lymph Nodes in Melanoma Patients Does not Provide Reliable Nodal Staging: Results from a Large Multicenter Trial.
    Ann Surg. 2019 Jun 7. doi: 10.1097/SLA.0000000000003405.
    PubMed     Text format     Abstract available


    Ann Surg Oncol

  2. NELSON DW, Fischer TD, Graff-Baker AN, Dehal A, et al
    Impact of Effective Systemic Therapy on Metastasectomy in Stage IV Melanoma: A Matched-Pair Analysis.
    Ann Surg Oncol. 2019 Jun 10. pii: 10.1245/s10434-019-07487.
    PubMed     Text format     Abstract available


    Anticancer Res

  3. KWON J, Kim YA, Lee C, Kim BH, et al
    Clinical Outcomes of Isolated Regional Lymph Node Recurrence in Patients With Malignant Cutaneous Melanoma.
    Anticancer Res. 2019;39:3147-3157.
    PubMed     Text format     Abstract available


    Cancer Res

  4. DAS SK, Pradhan AK, Bhoopathi P, Talukdar S, et al
    The MDA-9/Syntenin/IGF-1R/STAT3 axis directs prostate cancer invasion.
    Cancer Res. 2018 Mar 23. pii: 0008-5472.CAN-17-2992.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  5. TOKI MI, Merritt CR, Wong PF, Smithy JW, et al
    High-plex predictive marker discovery for melanoma immunotherapy treated patients using Digital Spatial Profiling.
    Clin Cancer Res. 2019 Jun 12. pii: 1078-0432.CCR-19-0104.
    PubMed     Text format     Abstract available


    J Invest Dermatol

  6. FANG S, Xu T, Xiong M, Zhou X, et al
    Role of immune response, inflammation and tumor immune response-related cytokines/chemokines in melanoma progression.
    J Invest Dermatol. 2019 Jun 6. pii: S0022-202X(19)31626.
    PubMed     Text format     Abstract available


    PLoS One

  7. LI Y, Li M, Shats I, Krahn JM, et al
    Glypican 6 is a putative biomarker for metastatic progression of cutaneous melanoma.
    PLoS One. 2019;14:e0218067.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: